An open-label trial to compare exposures of subcutaneous long-acting injectable use olanzapine (TV-44749) versus oral olanzapine in adults with schizophrenia (ORBIT)

Mar 29, 2026 — 4:45 PM - 4:50 PM
Exhibition Hall

Schizophrenia and Other Psychotic Disorders

Presenter:

Krzysztof Duma (Netherlands)

Session Type

E-Poster Presentation

An open-label trial to compare exposures of subcutaneous long-acting injectable use olanzapine (TV-44749) versus oral olanzapine in adults with schizophrenia (ORBIT)